Lana Markey · Study 2023-0621 · Dr. Andreeff, MD Anderson
Latest labs: 2026-05-12 · Built 2026-05-12 11:08:55 This dashboard refreshes automatically every day at 9:30 AM CT build#2135 · motion=on
TODAY · TUESDAY
May 12, 2026
Cycle 1
Day 23 of 35 · Watch week
66% through Cycle 1 · 18% through the first 4 cycles (trial can run up to 2 years)
Medicine schedule
💉NadunolimabNext in 13 days (May 25)
💉AzacitidineWeek starts in 13 days (May 25)
What Mom's Labs Say Today
Auto-generated from Mom's MyChart labs with AI assistance (Claude Sonnet). This is an informational summary, not medical advice or a clinical assessment — any questions or concerns should go to her care team at MD Anderson. Every numeric claim is verified against the source data.
Today is Day 23 of Cycle 1 — Lana is past the active treatment window and now in the recovery stretch, where the marrow does the slow work of rebuilding. Her Hgb (hemoglobin) came in at 9.1 today, up from 7.9 yesterday — that jump almost certainly reflects a red cell transfusion she received on May 11 (more on that below). Her ANC (neutrophils) is 0.2, which is severely low, and her platelet count is 25 — both very much in the zone we'd expect at this point in induction. Her white count also dropped sharply today to 0.9, which the team will be watching closely.
Her liver numbers — ALT 17, AST 15, bilirubin 0.3 — are calm and have been steady all week. Kidney function looks good too; creatinine is 0.74 and has been stable. One number worth noting is alkaline phosphatase, which has been quietly climbing across the past week (62 on May 6, up to 110 today). Her team is aware; it hasn't crossed into concerning territory, but it's a trend Megan will see on the data card.
She received a unit of red blood cells on May 11 — her hemoglobin had drifted down to 7.9 before the transfusion, and today's 9.1 reflects that support landing. Transfusions at this stage of induction are completely routine and expected; this is the marrow doing very little on its own right now, which is exactly what aggressive induction looks like. Platelets remain low at 25, and the team will be watching whether a platelet transfusion becomes needed.
How Mom's Likely Feeling Today 💛
🔋 Energy. Hgb 9.1 after yesterday's transfusion — probably a bit less winded than the past few days.
🛡️ Infection. ANC 0.2 — severely neutropenic; the team is watching her very closely right now.
📈 Inflammation. LDH has edged up to 175 this week — any bone aches may still be present.
🤢 Stomach. Day 23, past the AZA window — her stomach is probably starting to settle.
Net read: transfusion helping energy; infection risk is the main focus now.
Crossed into a alert zone — was watch. Worth flagging.
▲
Hemoglobin: 7.9 → 9.1(+1.2 g/dL)
Improved out of the watch zone into normal. Good direction.
1The Journey
Treatment timeline and what's coming up
This is the tentative plan right now. Nothing is locked in. The team will adjust based on how Mom responds, how her body handles each drug, and whether transplant becomes a real option. She could do fewer cycles, or more. Dates can shift. Treatment can continue up to 2 years total. Think of this as the current roadmap, not a fixed schedule.
The journey · First 4 cycles shown · Apr 20 → Aug 16 (may continue)
← swipe to see the full timeline →
C1
C2
C3
C4
Apr 20
May 24
Jun 21
Jul 19
Aug 16
Today
Nadunolimab infusion
Azacitidine week
Watch week (nadir)
Note: The trial can run up to 2 years. This chart shows the first 4 cycles as the initial window — Mom may continue past Aug 16 depending on her response and when a transplant is ready.
What's coming up
In 12 days
End of Cycle 1 · bone marrow biopsy
Sunday · May 24
In 13 days
Nadunolimab infusion
Monday · May 25
In 13 days
Azacitidine week begins
Monday · May 25
2The Numbers
Daily labs, transfusions, and the full data
Transfusions
7 detected — confirmed entries come from the manual log; inferred entries are deduced from lab jumps.
🩸 Transfusion log (7)
2026-04-02PRBC (1 unit)Pre-MDA transfusion at Aspirus. Hgb 8.0 → post-transfusion dilutional labs at MDA admit.(confirmed)
2026-04-06PRBC (red cells)Hgb +2.9, RDW -0.8 (revealed 2026-04-07 AM draw)(inferred from labs)
2026-04-11PRBC (red cells)Hgb +1.0, RDW +1.9 (revealed 2026-04-12 AM draw)(inferred from labs)
2026-04-22PRBC (red cells)Hgb +1.2, RDW +0.4 (revealed 2026-04-23 AM draw)(inferred from labs)
2026-04-24PRBC (red cells)Hgb +1.4, RDW -1.6 (revealed 2026-04-25 AM draw)(inferred from labs)
2026-05-01PRBC (red cells)Hgb +1.4, RDW -0.8 (revealed 2026-05-02 AM draw)(inferred from labs)
2026-05-11PRBC (red cells)Hgb +1.2, RDW -0.3 (revealed 2026-05-12 AM draw)(inferred from labs)
Blood Work
Daily labs from MD Anderson, ordered by day-to-day importance.
Green · on trackYellow · watchingRed · needs attention
Ordered by importance. The top row is what matters most day-to-day: ANC (infection risk), Hemoglobin (oxygen/energy), Platelets (bleeding risk), Blast % (disease activity), and RDW (marrow health).
= transfusion day (same as the 🩸 in the Full Data table)
Another liver/bile marker. Stable = plumbing's working.
14
Albumin
3.6g/dL▲ +0.3
Target ≥3.5 · ≤5.2 (MDA ref) · ↑ higher is better
Main blood protein. Low = could use more nutrition. Hers is a bit low.
Electrolytes — the balance panel
15
Potassium
4.4mmol/L▼ -0.3
Target ≥3.4 · ≤4.5 (MDA ref) · stay in range
Electrolyte. Right balance keeps the heart happy. Team watches this closely.
16
Uric acid
3.1mg/dL▼ -0.1
Target ≥2.4 · ≤5.7 (MDA ref) · stay in range
Waste from cells that are dying off. Allopurinol keeps it controlled.
17
Calcium
8.6mg/dL▼ -0.2
Target ≥8.2 · ≤10.2 (MDA ref) · stay in range
Electrolyte for bones, muscles, heart.
18
Phosphorus
2.8mg/dL▼ -1
Target ≥2.5 · ≤4.5 (MDA ref) · stay in range
Electrolyte the team watches when cancer cells are dying off.
19
Magnesium
1.9mg/dL→
Target ≥1.6 · ≤2.6 (MDA ref) · stay in range
Electrolyte for muscles, nerves, heart. Easy to top up if low.
Full Data
Every value, every day. Colored cells flag out-of-range. 🩸 marks transfusion days.
Full Data
← swipe to see all dates →
Metric
04-01
04-07
04-08
04-09
04-10
04-11 🩸
04-12
04-13
04-14
04-15
04-16
04-17
04-18
04-19
04-20
04-21
04-22 🩸
04-23
04-24 🩸
04-25
04-26
04-27
04-28
04-29
04-30
05-01 🩸
05-02
05-03
05-04
05-05
05-06
05-07
05-08
05-09
05-10
05-11 🩸
05-12
ANC (neutrophils)
4.46
3.87
2.19
3.57
4.26
4.35
3.53
1.93
2.34
2.19
1.31
1.07
1.02
1.3
0.8
2.94
0.48
2.06
1.53
1.14
1.2
1.09
0.81
0.68
0.21
0.38
0.23
0.13
0.14
0.19
0.19
0.28
0.22
0.06
0.02
0.08
0.2
Hemoglobin
8
10.9
9.4
9
8.3
7.7
8.7
8.8
8.9
8.4
8.5
8.6
8.3
8.5
8.1
8.3
7.8
9
7.8
9.2
9.2
8.7
9
9
8.4
7.8
9.2
9.4
9.3
9.5
9.2
9.6
8.9
8.5
8.3
7.9
9.1
Platelets
63
56
52
50
49
51
55
57
57
57
64
66
62
60
58
49
52
47
41
39
40
41
43
44
44
38
36
37
35
36
31
32
28
25
24
24
25
Peripheral blasts
4
4
5
12
6
6
4
11
12
10
13
14
10
7
5
2
3
5
3
3
2
3
1
1
—
—
—
—
—
—
—
—
—
—
—
—
—
RDW
21.2
20.4
20.3
20.5
20.1
19.7
21.6
20.8
20.5
20.2
20.1
20.1
20.2
20.4
20.5
20.8
20.7
21.1
20.5
18.9
18.9
18.4
18.5
18.6
18.8
18.9
18.1
18.1
18
17.9
17.7
17.8
17.6
17.7
17.8
17.5
17.2
White Blood Cells
6.75
7.9
7.3
8.3
8.2
6.9
7.5
9.2
9
8.1
7.7
7.1
6.8
5.4
5.7
4.2
4.4
7.1
5.9
5.7
4.3
4.2
2.6
3.4
3
2.4
2.5
3.3
3.5
3.1
3.2
3.5
3.1
3
2.3
2.5
0.9
ALT
12
27
27
25
24
41
59
61
57
50
44
40
34
38
41
49
45
35
24
20
17
17
18
18
15
16
23
23
22
20
17
16
15
17
17
16
17
AST
12
17
17
18
16
31
38
34
28
22
23
22
20
22
23
30
24
16
9
12
13
13
11
13
10
11
16
16
14
11
12
12
13
15
16
14
15
LDH
196
206
193
174
152
157
178
179
154
159
178
178
158
177
181
230
216
167
148
160
164
130
150
135
134
125
126
133
140
141
144
155
146
148
158
153
175
Creatinine
0.81
0.96
0.9
0.91
0.8
0.82
0.72
0.79
0.72
0.72
0.78
0.89
0.83
0.88
1.06
0.95
0.84
0.72
0.64
0.72
0.68
0.61
0.71
0.86
0.77
0.74
0.94
0.87
0.89
0.86
0.82
0.76
0.75
0.91
0.74
0.77
0.74
BUN
—
24
26
20
20
26
29
28
27
30
31
29
32
27
32
31
29
24
19
19
17
18
24
25
18
19
23
21
23
22
22
21
23
23
20
22
19
Bilirubin
—
0.6
0.4
0.7
0.4
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.6
0.4
0.3
0.4
0.3
0.3
0.4
0.5
0.3
0.4
0.6
0.4
0.3
0.5
0.6
0.3
0.3
0.3
0.3
0.3
Alk Phos
—
88
76
75
74
69
67
66
73
67
67
72
71
76
76
80
73
70
65
71
67
62
66
61
58
54
57
55
57
60
62
71
74
74
86
90
110
Albumin
3.6
—
3.3
3
2.9
2.8
2.7
2.8
2.8
2.8
2.8
2.9
3.1
3.2
3.2
3.2
3.2
3.2
2.9
2.9
2.9
2.9
3
2.9
3
2.9
2.9
3.1
3.2
3.3
3.4
3.6
3.5
3.3
3.4
3.3
3.6
Potassium
—
4.6
4.7
4.1
4.5
4.4
4.4
4.5
4.4
4.4
4
4.2
3.9
4
4.2
4.7
3.7
4
3.9
3.7
4.3
4.1
4.1
3.5
3.8
3.9
4
3.8
4.3
4
4.4
4.4
4.4
4.5
4.3
4.7
4.4
Uric acid
—
—
3
2.6
2.3
2.1
2
2.1
2.2
2.1
2.2
2.5
2.6
2.7
2.4
3.1
3.2
3.1
2.7
2.6
2.8
2.6
2.6
2.9
2.9
2.7
2.9
2.8
2.9
3.1
3.3
3.3
3.3
3.6
3.4
3.2
3.1
Calcium
—
—
—
9
9.3
8.8
9
9.1
8.9
8.9
8.8
8.9
9.1
9
8.8
9
8.8
9
8.8
8.7
8.8
8.8
8.9
9
9
8.6
8.8
9.3
9.1
9
9.1
9.2
9.1
9.1
8.9
8.8
8.6
Phosphorus
—
—
4.1
3.7
3
2
3
3.1
3
3.5
3.5
3.7
3.8
3.5
3.7
2.8
2.5
3.7
3.4
3.1
3.7
3.3
3.2
3.6
3.4
3.1
3.5
3.6
3.3
3.1
3.4
3.8
4
4.1
3.6
3.8
2.8
Magnesium
—
—
2.3
2.1
2.2
2.2
2.1
2.3
2.2
2.4
2.2
2.1
2.1
2
2
1.8
2
1.8
1.8
1.9
1.9
1.9
1.8
1.9
1.8
1.8
2.1
2.2
2.2
2.3
2.2
2.2
2
1.9
1.9
1.9
1.9
3The Plan
Each drug, the cycle structure, and watch weeks
The Regimen
What each drug does, why it's in her protocol, and when she takes it.
Study 2023-0621 · MD Anderson · Dr. Michael Andreeff
What she has:High-risk MDS (myelodysplastic syndrome) with TP53 mutation and 17p deletion. A bone-marrow condition that traces back to chemo she had for breast cancer in 1993. She's formally MDS (7% immature cells), treated carefully because of her TP53 gene.
The plan: Two medicines teaming up, cycle by cycle (1 cycle ≈ 1 month). Trial can run up to 2 years. Goal: quiet the disease down enough to move toward a stem cell transplant — which offers the chance to heal fully. Transplant timing depends on her response, not a fixed number of cycles.
Nadunolimabinvestigational antibody, IV
🎯 Smart missile
Targets the cells that drive the disease, while leaving healthy cells alone.
C1: Days 1, 8, 22. C2+: Days 1 and 15 (every 2 weeks).
Azacitidine (AZA)FDA-approved, IV or small injection
🔄 Reset button
Flips helpful genes back on so cells behave more normally.
C1: Days 8–14 (7 days). C2+: Days 1–7 of each cycle.
She's Now In Cycle 1
The First Four Cycles
Cycle 1Apr 20 – May 24
Starting strong. Both medicines begin (Nadunolimab + Azacitidine).
Cycle 2May 25 – Jun 21
If counts recover and the team clears it, possible move to Rotary House. Nothing about this is locked in — depends entirely on her response and the team's call.
Cycle 3Jun 22 – Jul 19
Possible chance to come home for a stretch if she's ready. Tentative — depends on response.
Cycle 4Jul 20 – Aug 16
Team evaluates response — could lead to transplant or more cycles.
Beyond Cycle 4Aug 16 +
Trial can run up to 2 years. Treatment continues cycle by cycle as long as she's responding. Stem cell transplant happens whenever the team says she's ready and a donor match is confirmed — could be sooner, could be later.
Watch Weeks
Rough estimates of when Mom's blood counts might be at their lowest each cycle. These are educated guesses based on typical Azacitidine-induction timing. Her actual lowest week can shift earlier or later, can last longer, and might not always be the first cycle. The team watches her daily regardless, so think of these more as heads-up windows than hard predictions.
May 04 – May 18Cycle 1 watch window — Rough estimate of when her blood counts could be at their lowest during this cycle. Actual timing varies a lot patient to patient.
Jun 08 – Jun 21Cycle 2 watch window — Another likely dip window. Nadirs can get deeper over time, or not. Team adjusts as they learn her pattern.
Jul 05 – Jul 19Cycle 3 watch window — Third estimated dip. By now the team has a better feel for her rhythm, and these windows may shift.
Aug 03 – Aug 16Cycle 4 watch window — Last dip before a possible transplant conversation, depending on how she's responding.